Photo by Total Shape on Unsplash
Counterfeits of Anti-Obesity Medication & Weight Loss Drug Ozempic Reported
December 14, 2023
Navigating the choppy waters of weight loss, consumers are either willingly or unknowingly using unofficial replicas of the diabetes medication, Ozempic, repackaged as an anti-obesity solution. For some, the global shortage of official Ozempic medication is making them turn to an off-brand, compounded version, manufactured by local pharmacies.
This issue is on the rise in Australia and has many turning toward unauthorized versions of diabetes drugs like Ozempic and Mounjaro. Compounding pharmacies — operating under the radar — have been catering to this demand, producing and shipping these alternatives for popular anti-obesity medications nationwide. However, this is not isolated in Australia, as the U.S. has begun discovering counterfeit pens of these weight loss drugs in circulation. These counterfeit drugs pose dangerous health risks.
A significant development in this landscape is the major telehealth startup, Eucalyptus, gearing up to sell its version of compounded semaglutide, prepared with stringent safety measures. This move has created ripples amongst regulators and pharmaceutical companies that hold the original patents.
The increasing use and popularity of compounded versions of semaglutide and tirzepatide (found in Mounjaro) can be traced back to the worldwide shortages of these drugs. However, the regulatory standpoint presents a different perspective. According to Australia’s medicine regulator, Therapeutic Goods Administration (TGA), only Novo Nordisk is permitted to supply products containing semaglutide. The TGA has pointed out that compounded medications haven’t undergone thorough scrutiny for safety, quality, and efficacy.
Presently, compounding pharmacies can manufacture custom pharmaceuticals for patients who can’t access commercially produced alternatives. However, with a surge in demand for diabetes medications for weight loss, these pharmacies are now mass-producing these alternatives. The TGA warns these pharmacies of potential legal complications for mass production in anticipation of patient needs.
These pharmacies operate in a regulatory gray area but advocate for their services, stressing their strict adherence to TGA and the Pharmacy Board’s guidelines. They argue that their offerings provide Australians with essential medication in times of scarcity.
However, official manufacturers caution against using and prescribing these unofficial versions of their drugs. It’s crucial to tread cautiously while dealing with these alternatives, keeping in mind both regulation and health implications.
Recent News
Media Giants Depend on Sports As Content Shortages Rise
As Hollywood emerges from last year’s strikes, major media companies are turning to live sports to attract audiences and advertisers. This trend was evident during this year’s Upfront presentations, where media giants showcased their upcoming content and advertising opportunities.
New Trader Joe’s Opens in SF After 10 Years
San Francisco’s Hayes Valley neighborhood welcomed a highly anticipated new addition on May 17, 2024, with the grand opening of a Trader Joe’s at 555 Fulton St., on the corner of Laguna Street. This event marks the end of a decade-long wait for residents who have been eagerly looking forward to a new grocery store in their area.
China’s Property Market Boost: Stocks Surge, Copper Hits Highs
The Chinese government unveiled a comprehensive support package that has sent ripples through financial markets. This initiative includes a slew of measures aimed at stimulating housing demand and addressing the excess inventory burdening developers. The immediate impact was a significant rally in Chinese stocks and a surge in commodity prices, notably copper, which hit record highs.
Mercedes-Benz Workers in Alabama Reject Union
In a pivotal moment for autoworkers in the southern United States, employees at a Mercedes-Benz plant in Alabama have voted against joining the United Auto Workers (UAW) union. The outcome, with 56% of workers voting against unionization and 44% in favor, comes as a significant setback for the UAW’s efforts to expand its influence in the region.